CLINICAL_TRIALS
research
· 2024-07-10
Clinical Trial Update: A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease [Phase 2]
Summary
Telios Pharma is evaluating TL-925 ophthalmic emulsion for dry eye disease in a Phase 2 trial that is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Telios Pharma, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING